0001209191-16-139142.txt : 20160830
0001209191-16-139142.hdr.sgml : 20160830
20160830163814
ACCESSION NUMBER: 0001209191-16-139142
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160826
FILED AS OF DATE: 20160830
DATE AS OF CHANGE: 20160830
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DNIB UNWIND, INC.
CENTRAL INDEX KEY: 0001385228
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 325 VASSAR STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6174913400
MAIL ADDRESS:
STREET 1: 325 VASSAR STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: BIND Therapeutics, Inc
DATE OF NAME CHANGE: 20130612
FORMER COMPANY:
FORMER CONFORMED NAME: BIND Biosciences, Inc
DATE OF NAME CHANGE: 20130130
FORMER COMPANY:
FORMER CONFORMED NAME: BIND Biosciences Inc
DATE OF NAME CHANGE: 20070105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LYNCH DANIEL
CENTRAL INDEX KEY: 0001177082
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36072
FILM NUMBER: 161861050
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-08-26
0
0001385228
DNIB UNWIND, INC.
BIND
0001177082
LYNCH DANIEL
C/O BIND THERAPEUTICS, INC.
325 VASSAR STREET
CAMBRIDGE
MA
02139
1
0
0
1
Chairman
Common Stock
2016-08-26
4
M
0
20000
0.44
A
20000
D
Employee Stock Option (Right to Buy)
0.44
2016-08-26
4
M
0
20000
0.00
D
2026-06-20
Common Stock
20000
0
D
This option became fully vested and exercisable as a result of the sale of substantially all of the assets of DNIB Unwind, Inc. (f/k/a BIND Therapeutics, Inc.) (the "Company") on August 1, 2016 (the "Sale"). The Sale constituted a Change in Control (as defined in the Company's 2013 Incentive Award Plan).
/s/ Daniel Lynch
2016-08-30